{"id":"W2051904394","doi":"10.1097/hco.0b013e3283540857","title":"Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation","year":2012,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"Pfizer","keywords":"Medicine; Apixaban; Atrial fibrillation; Rivaroxaban; Dabigatran; Warfarin; Randomized controlled trial; Stroke (engine); Population; Internal medicine; Intensive care medicine; Cardiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0114745,0.0004192605,0.02173076,0.001078299,0.00001800354,0.00001110076,0.00009714068,0.0005076752,0.00005123438],"category_scores_gemma":[0.006813308,0.0002826504,0.007553568,0.0002716277,0.00006109894,0.00007760462,0.0000569529,0.0002141088,0.00001135593],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000129067,"about_ca_system_score_gemma":0.0004127257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001032635,"about_ca_topic_score_gemma":0.000001277093,"domain_scores_codex":[0.9907368,0.003782073,0.00450888,0.0003779405,0.0002566395,0.0003376889],"domain_scores_gemma":[0.9911702,0.005871892,0.002522097,0.0002677676,0.00008598086,0.00008201061],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.07759798,0.000005395932,0.003910282,0.01230371,0.002073532,2.429635e-7,0.00002620963,0.0000852903,2.220691e-7,0.0008595415,0.0004968659,0.9026407],"study_design_scores_gemma":[0.3354576,0.00006928608,0.0001569419,0.005442797,0.005668185,0.000004813175,0.000005173918,0.00008207538,9.358077e-8,0.0002336856,0.6527033,0.0001760036],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004612644,0.9674513,0.002509014,0.00007518567,0.01389573,0.01587502,0.00006934923,0.00002066992,0.00005760966],"genre_scores_gemma":[0.0002459697,0.9827302,0.0002311597,8.293307e-7,0.01476262,0.0000839312,0.001663756,0.00003145317,0.0002500854],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9024647,"threshold_uncertainty_score":0.9999626,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4626622080755708,"score_gpt":0.5265098728002774,"score_spread":0.0638476647247066,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}